Hjem › Kronisk myelogen leukemi › Alabama › Birmingham
Kliniske studier for Kronisk myelogen leukemi i Birmingham, AL
6 studier for Kronisk myelogen leukemi søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RekruttererFase 3
- Ascentage Investigative Site #1044, Birmingham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- University of Alabama at Birmingham, Birmingham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- University of Alabama Birmingham, Birmingham
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RekruttererFase 1/2
- University of Alabama Medicine (UAB Medicine), Birmingham
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
RekruttererObservasjonsstudie
- University of Alabama, Birmingham, Birmingham
Kronisk myelogen leukemi-studier i andre byer
- Houston, TX18 studier
- New York City, NY11 studier
- Seattle, WA11 studier
- Philadelphia, PA6 studier
- Portland, OR6 studier
- Detroit, MI6 studier
- Baldwin Park, CA6 studier
- Chicago, IL6 studier
- Durham, NC5 studier
- Nashville, TN5 studier
- Boston, MA5 studier
- Baltimore, MD5 studier
Andre studier i Birmingham
- Kreft (alle typer)31 studier
- Brystkreft24 studier
- Eggstokkreft23 studier
- Fedme23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Type 2-diabetes16 studier
- Endometriekreft16 studier
- Overvekt16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.